MeSH tree: C06.130.120
QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology analysis to give pathologists "super vision" to detect hidden genetic markers of cancer in standard patient ...
May 6, 2026
0
9
When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must determine whether the cause is cancer or a benign condition. The location of these ...
Mar 27, 2026
0
6
A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an anti-inflammatory and ...
Dec 23, 2025
0
15
Parenteral nutrition (PN) is a lifesaving means of nutritional support for thousands of hospitalized infants who cannot tolerate normal oral feeding due to the immaturity or surgical removal of the intestine due to congenital ...
Dec 9, 2025
0
6
Nagoya University researchers and their collaborators have found that minimally invasive laparoscopic surgery significantly reduces blood loss and improves jaundice recovery compared to traditional open surgery for treating ...
Nov 25, 2025
0
10
While gastrointestinal (GI) endoscopy is rarely performed during pregnancy—accounting for just 0.4% of procedures—there are times when it is urgently needed. A new review by physician-scientists from Beth Israel Deaconess ...
Aug 13, 2025
0
12
Primary sclerosis cholangitis, PSC in short, is a rare liver disease that destroys the bile ducts. It is a severe condition for which we currently have no effective treatments and often results in the patient requiring a ...
Jun 11, 2025
0
28
A team of researchers at Baylor College of Medicine, UMass Chan Medical School and Cincinnati Children's Hospital Medical Center has developed a new treatment that could change the outlook for patients with Alagille syndrome. ...
May 29, 2025
0
12
Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
May 1, 2025
0
24
A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation ...
Mar 13, 2025
0
17
